| Nazwa produktu: |
25-DESACETYLO RIFAMPICYNA |
| Synonimy |
25-O-deacetylo-3-[(E)-[(4-metylo-1-piperazynylo)imino]metylo]ryfamycyna; desacetylryfampicyna; desacetylryfampicyna; 25-deacetylryfampicyna; (2S,8E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,17,19,21-pentahydroksy-23-metoksy-2,4,12,16,18,20,22-heptametylo-8-{[(4-metylopiperazyno-1-ylo)amino]metylideno}-2,7-(epoksypentadeka[1,11,13]trienoimino)nafto[2,1-b]furan-1,9,11(2H,8H)-trion; (2S,8E,16S,17S,18R,19R,20R,21S,22S,23S,24E)-5,6,17,19,21-pentahydroksy-23-metoksy-2,4,12,16,18,20,22-heptametylo-8-{[(4-metylopiperazyno-1-ylo)amino]metylideno}-2,7-(epoksypentadeka[1,11,13]trienoimino)nafto[2,1-b]furan-1,9,11(2H,8H)-trion |
| Angielska nazwa |
25-DESACETYL RIFAMPICIN;25-O-Deacetyl-3-[(E)-[(4-methyl-1-piperazinyl)imino]methyl]rifamycin; Desacetylrifampicin; Desacetylrifampin; 25-deacetylrifampicin; (2S,8E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{[(4-methylpiperazin-1-yl)amino]methylidene}-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-1,9,11(2H,8H)-trione; (2S,8E,16S,17S,18R,19R,20R,21S,22S,23S,24E)-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{[(4-methylpiperazin-1-yl)amino]methylidene}-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-1,9,11(2H,8H)-trione |
| MF |
C41H56N4O11 |
| Masie cząsteczkowej |
780.9035 |
| InChI |
InChI=1/C41H56N4O11/c1-20-11-10-12-21(2)40(53)43-31-26(19-42-45-16-14-44(8)15-17-45)36(50)28-29(37(31)51)35(49)25(6)38-30(28)39(52)41(7,56-38)55-18-13-27(54-9)22(3)33(47)24(5)34(48)23(4)32(20)46/h10-13,18-20,22-24,27,32-34,42,46-49,51H,14-17H2,1-9H3,(H,43,53)/b11-10+,18-13+,21-12+,26-19+/t20-,22+,23+,24-,27-,32-,33+,34+,41-/m0/s1 |
| Nr CAS |
16783-99-6 |
| Struktury molekularnej |
|
| Gęstość |
1.36g/cm3 |
| Współczynnik załamania |
1.644 |
| Symbole zagrożenia |
|
| Kody ryzyka |
|
| Bezpieczeństwo opis |
|
|
